Your browser doesn't support javascript.
loading
Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
Pathan, Asad Z; Aijaz, Saba; Sheikh, Sana; Sattar, Saadia.
Afiliação
  • Pathan AZ; Department of cardiology, Tabba Heart Institute Karachi, Karachi, Pakistan.
  • Aijaz S; Department of cardiology, Tabba Heart Institute Karachi, Karachi, Pakistan.
  • Sheikh S; Department of cardiology, Tabba Heart Institute Karachi, Karachi, Pakistan.
  • Sattar S; Department of cardiology, Tabba Heart Institute Karachi, Karachi, Pakistan.
Catheter Cardiovasc Interv ; 98(2): E181-E187, 2021 08 01.
Article em En | MEDLINE | ID: mdl-33655650
ABSTRACT

OBJECTIVES:

Primary

objectives:

to compare radial artery occlusion rate (RAO) after cardiac catheterization between catecholamine-chitosan pad (InnoSEAL) and pneumatic compression device (PCD) and to compare difference in hemostasis time and radial monitoring termination time between two arms. Secondary

objectives:

to compare radial site bleeding and ease of use of two methods by cath-lab technicians.

BACKGROUND:

Hemostatic pads may be an effective alternative to PCD with lesser chance of access site complications with advantage of shortened compression time.

METHODS:

Patients (N = 606) undergoing trans-radial, diagnostic or interventional procedures were randomized to either InnoSEAL arm or PCD. RAO was assessed using US Duplex; performed 6-24 hr posthemostatic device removal. Time to hemostasis was recorded as per defined protocols. Ease of use among cath-lab technicians was assessed through 5 point Likert scale.

RESULTS:

Data of 597 patients was analyzed (299 InnoSEAL, 298 PCD). RAO rate was 8.5% in InnoSEAL and 9.4% in PCD arm (p value >.05). The pooled median hemostasis time and time to termination of radial monitoring was 42 versus 225 min and 50 versus 240 min in InnoSEAL and PCD arms, respectively (p value <.01). There was no difference in Grade I/II hematoma (InnoSEAL 1.3% vs. PCD 3.4%). InnoSEAL was marginally acceptable compared to PCD by technicians.

CONCLUSION:

Hemostasis time is significantly shorter in InnoSEAL arm with reasonable acceptability to its usage among cath lab staff. RAO and bleeding complications are comparable between the arms. Based on our findings, it seems feasible to include Chitosan based hemostasis pad routinely in cath lab.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arteriopatias Oclusivas / Cateterismo Periférico / Quitosana Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arteriopatias Oclusivas / Cateterismo Periférico / Quitosana Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article